The Team

Lundbeckfonden Emerge is led by Christian E. Elling who works closely with the team of Lundbeckfonden Ventures and Lundbeckfonden as well as outside resources complementing the skillset of Lundbeckfonden Emerge.

Lundbeckfonden Emerge

Christian Elling

Managing Partner

Paul Little

Operating Partner

Lundbeckfonden Emerge


Dermtreat Announces First Patient Dosed in Phase 2b Clinical Trial of Rivelin Clobetasol for Oral Lichen Planus
28. July 2018
Dermtreat secures GMP manufacturing
4. September 2017
Dermtreat Raises USD 17.7 mill. From Sofinnova Ventures, Novo A/S and Lundbeckfonden
8. May 2017